关键词:抗体制备抗体标记重组蛋白表达

027-87877773
首页 > 产品中心 > 蛋白│多肽│抗体 > 药物对照抗体

Blinatumomab ( 兰妥莫单抗 )


<
>
产品品牌:Frdbio 产品货号:FrdE0020
保存温度:-20°C 有效日期:6个月
英文名称:Blinatumomab
规      格:
价      格:优惠价
在线咨询:

Product name:Blinatumomab ( 兰妥莫单抗 )

Catalog No. : FrdE0020

MW:54100.00 Da

Description:Blinatumomab is a BiTE-class (bi-specific T-cell engagers) constructed monoclonal antibody indicated for the treatment of Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).Blinatumomab is manufactured by Amgen Inc.and marketed under the brand Blincyto™.Blinatumomab was approved in December 2014 under the FDA’s accelerated approval program,which allows approval of a drug to treat a serious or life-threatening disease based on clinical data showing the drug has an effect on a surrogate endpoint reasonably likely to predict clinical benefit to patients.

Alternative names:Blinatumomab

Specificity target name;species:CD19/CD3E[Homo sapiens]

Form: Liquid

Receptor identification:(scFv-kappa-heavy)-(scFv-heavy-kappa)

Storage: Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 °C for frequent use. Store at -20 to -80 °C for twelve months from the date of receipt.

Purity:The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Note: This product is for research use only,not for diagnostic or therapeutic use.


相关产品

Mepolizumab ( 美泊珠单抗 )

福因德科技(武汉)有限公司©2008-2020 网站备案号:鄂ICP备17002573号-1   鄂公网安备: 42018502001815号